Effects of the sodium‐glucose cotransporter 2 inhibitor dapagliflozin on fluid distribution: A comparison study with furosemide and tolvaptanKen Ohara, Daisuke Nagata, Osamu Saitô et al.|Nephrology|2018Cited by 82
The extracellular volume status predicts body fluid response to SGLT2 inhibitor dapagliflozin in diabetic kidney diseaseKen Ohara, Daisuke Nagata, Takahiro Masuda et al.|Diabetology & Metabolic Syndrome|2020Cited by 66
Valacyclovir Neurotoxicity and Nephrotoxicity in an Elderly Patient Complicated by HyponatremiaTakuya Murakami, Daisuke Nagata, Tetsu Akimoto et al.|Drug Target Insights|2018Cited by 9
Renal Failure Found during the Follow-up of Sarcoidosis: The Relevance of a Delay in the Diagnosis of Concurrent HypercalcemiaErika Hishida, Daisuke Nagata, Takahiro Masuda et al.|Internal Medicine|2016Cited by 5
Nephrotic Syndrome and a Retroperitoneal Mass: A Case Report of a Patient with Recurrent Invasive ThymomaHiroaki Myoga, Daisuke Nagata, Tetsu Akimoto et al.|Internal Medicine|2017Cited by 3